Cardinal Health, Inc. (CAH) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of Cardinal Health, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
CAH
Cardinal Health, Inc.
$232.65HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT
REGN
Regeneron Pharmaceuticals, Inc.
$774.11HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT
Total return — CAH vs REGN
growth of $100 · dividends reinvested · last 10yCAH +281.8% (+14.3%/yr)REGN +97.4% (+7.0%/yr)CAH compounded faster over this window
CAH REGN
CAH vs REGN: by the numbers
- •REGN is the larger company ($79.75B vs $54.49B market cap).
- •REGN trades at the lower trailing earnings multiple (19.15 vs 32.18 P/E), one valuation lens rather than an overall verdict.
- •REGN converts more revenue to profit (27.86% vs 0.67% net margin).
- •CAH grew revenue faster over the past five years (9.37% vs 4.64% CAGR).
- •CAH pays the higher dividend yield (0.87% vs 0.47%).
Metrics side by side
Valuation
| Metric | CAH | REGN |
|---|---|---|
| P/E ratio | 32.18 | 19.15 |
| Forward P/E | 18.55 | 14.20 |
| P/S ratio | 0.21 | 5.13 |
| P/B ratio | N/A | 2.51 |
| EV / EBITDA | 16.69 | 17.62 |
| FCF yield | 8.30% | 4.42% |
Profitability
| Metric | CAH | REGN |
|---|---|---|
| Gross margin | 3.84% | 84.86% |
| Operating margin | 1.03% | 25.56% |
| Net margin | 0.67% | 27.86% |
| ROE | N/A | 13.65% |
| ROIC | 13.45% | 9.19% |
Dividends
| Metric | CAH | REGN |
|---|---|---|
| Dividend yield | 0.87% | 0.47% |
| Payout ratio | 28.33% | 9.15% |
Growth (annualized)
| Metric | CAH | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 9.37% | 4.64% |
| EPS CAGR (5Y) | 28.32% | 5.70% |
| FCF CAGR (5Y) | 17.40% | 15.77% |
| Total return CAGR (5Y) | 37.70% | 3.93% |
Frequently asked
- Which has the lower trailing P/E, CAH or REGN?
- REGN has the lower trailing P/E: CAH trades at 32.18 and REGN at 19.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, CAH or REGN?
- Over the past five years, CAH grew revenue faster — CAH at a 9.37% CAGR versus REGN at 4.64%.
- Does CAH or REGN pay a bigger dividend?
- CAH yields 0.87% and REGN yields 0.47% based on trailing dividends and the latest price.
- Is CAH or REGN more profitable?
- REGN runs the higher net margin — CAH at 0.67% versus REGN at 27.86%.
- How have CAH and REGN total returns compared?
- Over the past 10 years, CAH delivered 14.67% and REGN delivered 7.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cardinal Health P/E ratioRegeneron Pharmaceuticals P/E ratioCardinal Health dividend yieldRegeneron Pharmaceuticals dividend yieldCardinal Health ROERegeneron Pharmaceuticals ROECardinal Health operating marginRegeneron Pharmaceuticals operating marginCardinal Health revenue growthRegeneron Pharmaceuticals revenue growthCardinal Health free cash flowRegeneron Pharmaceuticals free cash flow
Cardinal Health & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.